scholarly journals Acute myeloid leukemia in an 86-year-old man with AML1/ETO treated with Homoharringtonine and Arsenic Trioxide

Medicine ◽  
2019 ◽  
Vol 98 (13) ◽  
pp. e14998
Author(s):  
Zhipeng He ◽  
Meiling Chen ◽  
Yiping Huang ◽  
Lili Chen ◽  
Bixin Wang ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Arsenic Trioxide ◽  
Myeloid Leukemia ◽  
Acute Myeloid

scholarly journals Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia

Cancer ◽  
2008 ◽  
Vol 113 (9) ◽  
pp. 2504-2511 ◽  
Author(s):  
Gail J. Roboz ◽  
Ellen K. Ritchie ◽  
Tania Curcio ◽  
Juliette Provenzano ◽  
Rebecca Carlin ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Arsenic Trioxide ◽  
Acute Promyelocytic Leukemia ◽  
Older Patients ◽  
Myeloid Leukemia ◽  
Low Dose ◽  
Promyelocytic Leukemia ◽  
Low Dose Cytarabine ◽  
Acute Myeloid

scholarly journals Correction to: Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia

2020 ◽  
Vol 12 (1) ◽  
Author(s):  
Jessica M. Salmon ◽  
Michael Bots ◽  
Eva Vidacs ◽  
Kym L. Stanley ◽  
Peter Atadja ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Arsenic Trioxide ◽  
Survival Benefit ◽  
Myeloid Leukemia ◽  
Significant Survival Benefit ◽  
Significant Survival ◽  
Apoptotic Effect ◽  
Acute Myeloid

An amendment to this paper has been published and can be accessed via the original article.

Sign in / Sign up

Export Citation Format

Share Document